February 27, 2026 · Form 4 insider transaction
Krishnan Suma bought 5,725 shares of Krystal Biotech, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
These same shares are also being reported on a Form 4 by the Reporting Person's spouse, Krish S. Krishnan.; 22,900 restricted stock units ("RSUs") were granted on February 28, 2025, to the Reporting Person's spouse, Krish S. Krishnan. Each RSU represents a contingent right to receive one share of the Company's common stock, subject to the Reporting Person's spouse continued service to the Company on each applicable vesting date. The RSUs vest ratably over a four-year period with the first installment, or 5,725 RSUs, vesting on February 27, 2026.; Directly beneficially owned by Krish S. Krishnan, the spouse of the Reporting Person.